Evidence map›Paper›PMID 32966773›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2020

METTL3-Regulated m

Susmita Sahoo

Abstract readComment
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. METTL14-dependent NExperimental & molecular medicine · 2026
    Article
  2. Progression of mCell death discovery · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Susmita SahooCardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: susmita.sahoo@mssm.edu.

Funding

Extracellular Vesicle-Encapsulated AAVs for Therapeutic Gene Delivery to the HeartR01HL148786 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Kiyotake Ishikawa, Susmita Sahoo · 2019 to 2026
$4.1M
Predictive and systems modeling of exosome cargoR01HL145644 · NHLBI · EMORY UNIVERSITY · PI DAVIS, MICHAEL E · 2019 to 2022
$3.1M
Therapeutic Mechanisms of Human CD34 ExosomesR01HL124187 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SAHOO, SUSMITA · 2014 to 2018
$2.1M
Dysregulated Adenosine Methylation of mRNA as a Novel Mechanism of Heart FailureR01HL140469 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SAHOO, SUSMITA · 2018 to 2021
$1.7M
NHLBI NIH HHS R01 HL124187NHLBI NIH HHS R01 HL140469NHLBI NIH HHS R01 HL145644NHLBI NIH HHS R01 HL148786
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenosineNeovascularization, PathologicHumansMethyltransferasesRNA, MessengerRoleAdenosineMethyltransferasesMETTL3 protein, humanN-methyladenosineRNA, Messenger

Identifiers

PMID32966773
PMCPMC7544999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.